Authors/Disclosures
|
Ronald M. Lazar, PhD, FAHA, FAAN, FAAN
(University of Alabama At Birmingham)
|
Dr. Lazar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DiaMedica Therapeutics Inc. . The institution of Dr. Lazar has received research support from National Institutes of Health. Dr. Lazar has received publishing royalties from a publication relating to health care. |
|
Andrea Lendaris, MD, MS
(Icahn School of Medicine at Mount Sinai)
|
Dr. Lendaris has nothing to disclose. |
|
Lauren E. Dunn, MD
(Ochsner Health System)
|
Dr. Dunn has nothing to disclose. |
|
|
No disclosure on file |
|
Randolph S. Marshall, MD, FAAN
(Columbia University)
|
The institution of Dr. Marshall has received research support from NIH. Dr. Marshall has received publishing royalties from a publication relating to health care. |
|
|
No disclosure on file |
|
Norman Putzki, MD
(Novartis Pharma AG)
|
No disclosure on file |